How do you decide?' Cancer patients die waiting for CAR-T therapy

“And people are dying. About 20% of all our patients together are actually dying before they can get CAR-T,” said Krina Patel, director of the myeloma cell therapy program at MD Anderson.

Manufacturing challenge leads to death in CAR-T trial

FDA Approves Carvykti CAR T-Cell Therapy for Multiple Myeloma - NCI

Value of Reducing Wait Times for Chimeric Antigen Receptor T-Cell Treatment: Evidence From Randomized Controlled Trial Data on Tisagenlecleucel for Diffuse Large B-Cell Lymphoma - ScienceDirect

CAR T Cell Therapy May Eliminate Tumor Cells Missed by Surgery

Immunotherapy for leukemia: Types, success rate, and more

Research project aims to make CAR-T-cell therapy safer and more effective, College of Medicine

Canadian cancer survivor works with the NRC for broader access to CAR-T therapy - National Research Council Canada

Mechanisms of resistance to CAR T cell therapy

Waiting Period: Definition, Types, and Examples

Biopharmaceutical Development Program Produces Personalized Anticancer Medicine for Young People with Cancer

DLBCL Relapse Chances and Treatment Options

Rolling the Dice: Gamble Pays Off For Cancer Patient in CAR T-Cell Clinical Trial

Need CAR T cell therapy? Here's what to expect

Lifesaving cancer therapy may itself CAUSE cancer, FDA warns